NCT03957031Completed
Gastric Cancer Risk Factors Associated With EU and CELAC Populations
Source: ClinicalTrials.gov · Last updated 9 May 2024
Brief summary (registry, in English)
The study uses a case-control design that examines the differences in types of exposures between cases defined with a pathological confirmation of GC diagnosis, and controls, defined as patients to whom a gastroscopy was indicated and confirmed absent of GC i
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1600 (actual)
- First submitted
- 17 May 2019
- Start date
- 31 May 2019
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT03957031
What you commit to
- Study type: Observational
- Participants enrolled: 1600
- From 31 May 2019 to the primary completion date, 31 Dec 2023
- 8 sites in 7 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Cases
- Inclusion criteria
- Subjects ≥18 years old.
- GC diagnosis (including gastroesophageal junction cancer) from IPATIMUP, INCAN, VUMC, PUC, VHIO, IAF, INCLIVA and GENPAT centres, in the last six months before his/her inclusion in the study.
- Has given and signed the IC to participate in this study.
- Exclusion criteria:
- Patients diagnosed with GC (including gastroesophageal junction cancer) from other centres/ countries not participating in this proposal.
- Patients with suspected with GC diagnosis but not confirmed by the pathological report.
- Controls
- Inclusion criteria
- Subjects ≥18 years old.
- Subjects to whom a gastroscopy was indicated in its medical care and confirmed absent of GC in the same centres will be matched in age (+/- 10 years), gender and pertaining from the same region of the GC case. Thus, to match our GC cases same number of controls is expected to be recruited.
- Has given and signed the IC to participate in this study.
- Exclusion criteria:
- Subjects from a different geographic area from the cases.
- Patients with high suspicion of GC (including gastroesophageal junction cancer) or previous personal history known of document chronic gastritis diagnosed by endoscopy and confirmed by histology.
Age in the registry: 18 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (8)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Alexander Fleming Coordinator of this site? Confirm its status | Buenos Aires | Argentina | Unknown status |
| Pontificia Universidad Catolica de Chile Coordinator of this site? Confirm its status | Santiago | Chile | Unknown status |
| Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron (VHIO) Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
| Hospital Clinico Universitario de Valencia Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
| Instituto Nacional de Cancerologia Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
| VU Medical Centre Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Unknown status |
| Institute of Pathology and Immunology of University of Porto Coordinator of this site? Confirm its status | Porto | Portugal | Unknown status |
| GenPat Coordinator of this site? Confirm its status | Asunción | Paraguay | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.